Senior insider sale
Chief Business Officer at ARBUTUS BIOPHARMA CORP — senior position signals high conviction
$78.1K
23.79K shares
What this filing means
MCELHAUGH MICHAEL J. plans to sell 23.79K shares of ARBUTUS BIOPHARMA CORP valued at approximately $78.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2025ACC: 0001447028-25-000029
Officer· Chief Business Officer
Since Dec 2018
23.79K
Shares to sell
$78.1K
Approx. market value
23.79K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
2/3/2025
23.79KTotal acquired23.79K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2025 | Restricted Stock Unit Vesting Compensation | 23.79K | — |
| Total | 23.79K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
23.79K
Market value
$78.1K
2/4/2025
Total
Units
23.79K
Value
$78.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/4/2025 | 23.79K | $78.1K | NASDAQ | Planned |
| Total | 23.79K | $78.1K | ||